StockNews.com Begins Coverage on Edap Tms (NASDAQ:EDAP)

Stock analysts at StockNews.com began coverage on shares of Edap Tms (NASDAQ:EDAP - Get Free Report) in a report issued on Wednesday. The firm set a "hold" rating on the medical equipment provider's stock.

A number of other analysts have also weighed in on the stock. Piper Sandler cut their price objective on shares of Edap Tms from $5.00 to $4.50 and set an "overweight" rating on the stock in a research note on Friday, March 28th. HC Wainwright reissued a "buy" rating and set a $19.00 price target on shares of Edap Tms in a report on Friday, March 28th. Finally, Jefferies Financial Group reissued a "hold" rating and set a $2.00 price target (down from $8.00) on shares of Edap Tms in a report on Friday, April 4th.

Edap Tms Stock Down 7.0%

NASDAQ:EDAP traded down $0.16 during mid-day trading on Wednesday, reaching $2.07. The company's stock had a trading volume of 35,746 shares, compared to its average volume of 96,778. Edap Tms has a 1 year low of $1.26 and a 1 year high of $7.11. The stock has a fifty day moving average of $1.96 and a 200-day moving average of $2.27. The firm has a market capitalization of $76.62 million, a PE ratio of -3.18 and a beta of 0.13. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08.

Edap Tms (NASDAQ:EDAP - Get Free Report) last announced its earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.06. The business had revenue of $22.69 million during the quarter, compared to the consensus estimate of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. Equities research analysts forecast that Edap Tms will post -0.6 earnings per share for the current year.

Institutional Trading of Edap Tms

Several institutional investors have recently modified their holdings of EDAP. Rock Springs Capital Management LP boosted its position in Edap Tms by 1.5% during the fourth quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider's stock worth $3,518,000 after acquiring an additional 23,800 shares during the last quarter. Schonfeld Strategic Advisors LLC boosted its position in Edap Tms by 48.5% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider's stock worth $355,000 after acquiring an additional 52,500 shares during the last quarter. Cetera Investment Advisers boosted its position in Edap Tms by 33.9% during the first quarter. Cetera Investment Advisers now owns 75,000 shares of the medical equipment provider's stock worth $147,000 after acquiring an additional 19,000 shares during the last quarter. Millennium Management LLC boosted its position in Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider's stock worth $108,000 after acquiring an additional 33,558 shares during the last quarter. Finally, BNP Paribas Financial Markets boosted its position in Edap Tms by 111.5% during the fourth quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider's stock worth $108,000 after acquiring an additional 25,650 shares during the last quarter. Institutional investors and hedge funds own 62.74% of the company's stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.